Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
about
Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA.Use of a small particle solid-core packing for improved efficiency and rapid measurement of sirolimus and everolimus by LC-MS/MS.Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation.LC-MS/MS for immunosuppressant therapeutic drug monitoring.Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples.Cyclosporine use in hematopoietic stem cell transplantation: pharmacokinetic approach.Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pDetermination of cyclosporine, tacrolimus, sirolimus and everolimus by liquid chromatography coupled to electrospray ionization and tandem mass spectrometry: assessment of matrix effects and assay performance.Microsphere-Based Rapamycin Delivery, Systemic Versus Local Administration in a Rat Model of Renal Ischemia/Reperfusion Injury.Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC-MS/MS systems.High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.On-line solid-phase extraction high-performance liquid chromatography-tandem mass spectrometry for the quantitative analysis of tacrolimus in whole blood hemolyzate.Dried blood spot analysis of creatinine with LC-MS/MS in addition to immunosuppressants analysis.A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimusDetermination of Immunosuppressive Pharmaceuticals in Whole Blood Following Kidney Transplantation by High-performance Liquid Chromatography–Tandem Mass SpectrometrySimultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS
P2860
Q34124314-FB523F17-F2C0-4A0D-B06F-E73A01A7ED62Q35792318-EDD8A54B-355B-4436-9E41-BAB54FEA35A7Q37620393-9932ADD0-C260-4978-B5C4-EB473CEF19A3Q37810219-5F23D96E-AC71-46F4-82F0-ADB010EA6B47Q37901027-C1E7EABD-6C4A-4C8D-B45B-F79FFFE534DBQ38562065-C6C4B349-A2A1-45C2-BB76-6995EC70EFD7Q41651902-92DD15CF-D249-473A-B9FC-E9A64DCDAE05Q42408786-C1CA1DFB-1003-4C63-891F-11F1A0801852Q42840545-82B1BFCC-B8A4-43F4-96FC-38E284005395Q43244555-4A4DB4F4-8BD5-4DB5-A487-0EF6829347D8Q48622461-79B314AE-EAF4-4B1A-9B85-65C5514E20C5Q53153590-87CB6741-D572-44D7-98A6-4A54FFBAA57CQ53156995-DA9E57E2-DE7F-4C8A-B30D-B4CF07417CF7Q53162140-8FBE596D-C05C-404D-88D1-18F097A91033Q56035477-0AE76A51-6E61-42DB-8D74-D421F18F65FBQ58249481-20AA7484-1A8B-4D35-BF4F-25FC66219458Q58914840-A630C582-5187-4B62-9E6F-7A8C7D0FA70B
P2860
Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@en
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@nl
type
label
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@en
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@nl
prefLabel
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@en
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@nl
P2093
P1476
Robust, high-throughput LC-MS/ ...... and sirolimus in whole blood.
@en
P2093
Donald R A Uges
Eli C F Dijkers
Remco A Koster
P304
P356
10.1097/FTD.0B013E318192304C
P577
2009-02-01T00:00:00Z